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ABSTRACT Staphylococcus aureus causes various diseases ranging from skin and
soft tissue infections to life-threatening infections. Adaptation to the different host
niches is controlled by a complex network of transcriptional regulators. Global proﬁl-
ing of condition-dependent transcription revealed adaptation of S. aureus HG001 at
the levels of transcription initiation and termination. In particular, deletion of the
gene encoding the Rho transcription termination factor triggered a remarkable over-
all increase in antisense transcription and gene expression changes attributable to
indirect regulatory effects. The goal of the present study was a detailed comparative
analysis of S. aureus HG001 and its isogenic rho deletion mutant. Proteome analysis
revealed signiﬁcant differences in cellular and extracellular protein proﬁles, most no-
tably increased amounts of the proteins belonging to the SaeR regulon in the Rho-
deﬁcient strain. The SaeRS two-component system acts as a major regulator of viru-
lence gene expression in staphylococci. Higher levels of SaeRS-dependent virulence
factors such as adhesins, toxins, and immune evasion proteins in the rho mutant re-
sulted in higher virulence in a murine bacteremia model, which was alleviated in a
rho complemented strain. Inhibition of Rho activity by bicyclomycin, a speciﬁc inhib-
itor of Rho activity, also induced the expression of SaeRS-dependent genes, at both
the mRNA and protein levels, to the same extent as observed in the rho mutant.
Taken together, these ﬁndings indicate that activation of the Sae system in the ab-
sence of Rho is directly linked to Rho’s transcription termination activity and estab-
lish a new link between antibiotic action and virulence gene expression in S. aureus.
IMPORTANCE The major human pathogen Staphylococcus aureus is a widespread
commensal bacterium but also the most common cause of nosocomial infections. It
adapts to the different host niches through a complex gene regulatory network. We
show here that the Rho transcription termination factor, which represses pervasive
antisense transcription in various bacteria, including S. aureus, plays a role in control-
ling SaeRS-dependent virulence gene expression. A Rho-deﬁcient strain produces
larger amounts of secreted virulence factors in vitro and shows increased virulence
in mice. We also show that treatment of S. aureus with the antibiotic bicyclomycin,
which inhibits Rho activity and is effective against Gram-negative bacteria, induces
the same changes in the proteome as observed in the Rho-deﬁcient strain. Our re-
sults reveal for the ﬁrst time a link between transcription termination and virulence
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regulation in S. aureus, which implies a novel mechanism by which an antibiotic can
modulate the expression of virulence factors.
KEYWORDS SaeRS TCS, Staphylococcus aureus, antisense transcription, bicyclomycin,
proteome, transcription termination
The Gram-positive bacterium Staphylococcus aureus causes various diseases rangingfrom skin and soft tissue infections to life-threatening infections such as endocar-
ditis, sepsis, and toxin-mediated diseases (1, 2). It is also a commensal that persistently
colonizes the skin and nasal cavity of about 20% of the human population (3, 4). A
complex regulatory network mediates the adaptation of S. aureus to the host during
colonization and infection. In particular, expression of genes involved in virulence and
bioﬁlm formation is tightly controlled by multiple regulatory systems comprising
two-component systems, transcription factors, the alternative sigma factor SigB, and
small regulatory RNAs (for reviews, see references 5 to 7). In addition, genomic
alterations caused by prophage induction contribute to changes in virulence factor
production in response to host factors and antibiotics (8–10).
A key regulator of virulence gene expression in staphylococci is the SaeRS two-
component system consisting of the membrane-bound SaeS sensor kinase and the
cytoplasmic SaeR DNA-binding response regulator (11). The Sae system contains two
additional proteins, the SaeP lipoprotein and the SaeQ membrane protein, which
modulate its activity by activating the phosphatase activity of SaeS (12). SaeS be-
longs to the family of so-called “intramembrane-sensing kinases,” which possess an
N-terminal domain composed of two transmembrane helices with a short extracyto-
plasmic linker and lack a speciﬁc extracytoplasmic sensory domain (13).
The Sae system responds to multiple stimuli (for a review, see reference 14),
including exposure to subinhibitory concentrations of human neutrophil peptides
(HNPs), the neutrophil protein calprotectin, or inhibitory concentrations of hydrogen
peroxide (15, 16). Induction of the SaeR regulon in a strain producing a constitutively
active form of the response regulator WalR suggested that the WalKR two-component
system, which is important for cell wall homeostasis, can positively affect the Sae
system (17). Although the molecular mechanism is unknown, recent results suggest
that this may be an indirect effect through interaction of the SpdC Abi-domain protein
with SaeS (18). Studies also reported a cross talk of the Sae system with other global
regulators, but to date there is no evidence for any direct regulatory interaction (14).
Typically, activation of the Sae system is required for target gene induction, whereas in
S. aureus Newman a single amino acid substitution in the transmembrane domain of
SaeS leads to strong constitutive kinase activity of SaeS and high constitutive expres-
sion of low-afﬁnity target genes (19). Target genes thought to have high-afﬁnity
binding sites for phosphorylated SaeR (hla and hlb) are insensitive to the saeS poly-
morphism, since the basal level of SaeR phosphorylation is sufﬁcient for their transcrip-
tion (19).
The Sae system controls the expression of approximately 40 genes, most of which
encode virulence factors such as adhesins, toxins, and immune evasion proteins
(20–27). It particularly activates the production of secreted proteins that are key factors
in the pathogenesis of S. aureus infections. Several SaeRS-dependent virulence factors
are involved in survival of S. aureus in the bloodstream (by interfering with chemotaxis
of immune cells or activation of complement and by lysis of phagocytic cells), dissem-
ination into host tissues, and formation of abscesses (28–30). In addition, the extracel-
lular adherence protein (Eap) and ﬁbronectin-binding proteins (FnbA and FnbB) en-
coded by SaeR regulon genes are major determinants facilitating invasion of
nonprofessional phagocytes such as epithelial and endothelial cells (31).
Gene expression is controlled at multiple levels beyond transcription initiation, one
of which is transcription termination, involving two major mechanisms (reviewed in
reference 32). In the case of intrinsic termination, which is universal to all bacteria,
dissociation of the elongation complex depends directly on the properties of the
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transcribed RNA sequence. The second mechanism relying on the Rho transcription
termination factor coexists with intrinsic termination in the vast majority of bacteria
(33). Rho is a homohexameric ring-shaped protein with RNA-dependent ATPase and
RNA-DNA helicase activities. Rho loads onto the nascent RNA, translocates 5= to 3= by
threading the RNA through its central pore until it encounters a paused elongation
complex, and then dissociates the RNA polymerase from the DNA and RNA (32). Most
of the knowledge on the molecular mechanisms and physiological roles of Rho-
dependent termination was gained by studies in Escherichia coli (reviewed in reference
34). Recent work has suggested that the essential role of Rho in E. coli lies in the
maintenance of chromosome integrity by controlling potentially deleterious tran-
scription-replication collisions (35). In particular, this involves removal of arrested
elongation complexes and prevention of extensive R-loop formation (36–38). Unlike in
E. coli and several other Gram-negative bacteria, Rho is dispensable in most Gram-
positive bacteria, including Bacillus subtilis and S. aureus (39, 40).
Rho is the target for the antibiotic bicyclomycin (BCM), which speciﬁcally binds to
Rho and interferes with its movement along the RNA, thereby inhibiting its action (41,
42). It was isolated from Streptomyces sapporonensis in 1972, and its protective effect in
vivo was shown in experimental mouse infections with clinical E. coli isolates (43). BCM
is effective against Gram-negative bacteria, because Rho is essential for their viability
(44). BCM was used for treatment of diarrhea in humans in the 1980s (45) and is
currently in use in veterinary medicine to treat gastrointestinal tract infections (41). In
recent efforts to address the growing problem of antimicrobial resistance by reviving
old compounds, its bactericidal potential gained by combination with inhibitors of
protein synthesis has been shown in in vitro studies (46).
In a large-scale transcriptome study using strand-speciﬁc tiling arrays, S. aureus
HG001, a derivative of the prototype strain NCTC 8325, was analyzed under multiple
experimental conditions covering a broad spectrum of the bacterium’s lifestyles, from
optimal in vitro growth to interaction with host cells (47). Classiﬁcation of noncoding
RNAs identiﬁed in this study revealed a relatively low abundance of antisense RNAs
(asRNAs) in the S. aureus wild type, where they overlap only 6% of the coding genes.
In line with studies showing that the transcription termination factor Rho plays a major
role in suppressing antisense transcription in Gram-negative and Gram-positive bacte-
ria, namely, E. coli (48), B. subtilis (49), and Mycobacterium tuberculosis (50), transcrip-
tome analysis of an S. aureus rho deletion mutant revealed a remarkable overall
increase in antisense transcription in the absence of Rho (47). The S. aureus rho mutant
exhibited a massive upregulation of transcript levels, particularly on the antisense
strand of protein coding genes. Generation of antisense transcripts resulted from
extended transcription beyond mRNA ends and transcription from cryptic low-level
promoters. Interestingly, the largest group of antisense transcripts was formed by those
detectable only in the rho mutant, i.e., initiating from promoters that are cryptic in
Rho-proﬁcient S. aureus. Additional transcriptome changes observed under Rho-
deﬁcient conditions resulted from altered expression of coding genes. These changes
are most likely indirect regulatory effects of Rho inactivation through altered activities
of transcriptional regulators.
Based on these observations, the goal of the present study was a detailed compar-
ative analysis of S. aureus HG001 and its isogenic rho deletion mutant as well as of the
effects of the antibiotic BCM on staphylococcal gene expression. Proteome analysis
revealed signiﬁcant differences in the abundances of several proteins, most notably
increased amounts of SaeRS-dependent virulence factors such as extracellular adher-
ence protein (Eap), chemotaxis inhibitory protein (CHIPS), and leukotoxins (HlgBC and
LukGH), under Rho-deﬁcient conditions. The in vivo relevance of increased virulence
factor production in the rho deletion mutant was conﬁrmed in a murine model of
bacteremia. Inhibition of Rho activity by BCM induced the expression of SaeRS-
dependent virulence factor genes, both on mRNA and on protein levels, to the same
extent as that observed in the rho deletion mutant.
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Effects of rho deletion on the S. aureus proteome. In a previous study, the impact
of Rho deﬁciency was investigated by comparatively proﬁling the transcriptomes of S.
aureus HG001 and an isogenic rho deletion mutant harvested during exponential
growth and 4 h after entry into stationary phase in RPMI and tryptic soy broth (TSB)
medium (47). This analysis revealed a strong overall increase in antisense transcription
in the absence of Rho as well as altered expression levels of many genes, the latter likely
due to indirect regulatory effects. In order to explore the differences in the cellular and
extracellular proteomes of S. aureus HG001 and the Δrho mutant ST1258 under the
same conditions as in the transcriptome study, cells and supernatants were collected
from exponential- and stationary-phase cultures in RPMI and TSB medium. In both
media, growth of the rho mutant was not signiﬁcantly different from that of the
parental strain (see Fig. S1 in the supplemental material). Mass spectrometry analysis
resulted in the quantiﬁcation of 1,347 proteins in the cellular proteome and 999
proteins in the exoproteome. Of these, 76 (cellular proteome) and 167 (exoproteome)
proteins showed signiﬁcantly different abundance (absolute fold change of 2) be-
tween HG001 and the rho mutant under at least one of the four conditions (Table S1).
Most of the differentially abundant cellular proteins (68/76) displayed increased
levels in the mutant. About one-fourth (18/68) of these proteins showed signiﬁcant
differences in levels in both media in at least one of the two growth phases. For seven
of these proteins, differential levels were common to all four conditions, among them
several virulence factors, namely, coagulase (Coa), the extracellular matrix protein-
binding protein (Emp), the LukGH leukocidin F-component (LukH), and the second
binding protein of immunoglobulin (Sbi).
In the exoproteome of the rho mutant, 131 proteins were present in signiﬁcantly
larger amounts than in the parental strain under at least one condition (Table S1). The
vast majority of these proteins were speciﬁc for either RPMI (74 proteins) or TSB
medium (37 proteins). During growth of S. aureus in RPMI medium, a particularly
pronounced impact of Rho deﬁciency was observed for staphylococcal superantigen-
like proteins, 12 of which (Ssl1 to Ssl9, Ssl12, Ssl13, and Ssl14) were at least 3-fold more
abundant in the supernatant of the mutant, all except Ssl8 and Ssl9 in both growth
phases. The remaining 20 of 131 proteins exhibited signiﬁcantly larger amounts in the
rho mutant during growth in both TSB and RPMI medium. The largest overlap (14
proteins) between TSB and RPMI was found in the exoproteome samples generated
from stationary-phase cultures, including four proteins (Coa, Sbi, and two proteins of
unknown function) with higher levels under all four conditions. One protein of un-
known function, SAOUHSC_00622, was present in strongly increased amounts in the
rhomutant in both proteomic fractions. Strongly decreased levels under all four growth
conditions were observed for the serine-aspartate repeat protein SdrD, a cell wall-
anchored adhesin, which was the most affected protein during growth in RPMI me-
dium.
Changes in gene expression levels in the rho mutant can result from (i) transcription
downstream of a Rho-dependent termination site (at transcript ends or associated with
transcripts not detectable in the wild type) extending into a coding region, (ii) down-
regulation of sense expression by antisense transcription on the opposite strand, and
(iii) indirect regulatory effects resulting from the impact of Rho deﬁciency on the level
and/or activity of transcriptional regulators (47). In order to examine the latter group,
we systematically analyzed the extent to which proteome changes in the rho mutant
can be linked to known regulators (Fig. 1A). Proteins monitored in our analysis
substantially covered transcription factor regulons that were extracted from RegPrecise
(51) and AureoWiki (52). However, there was in general no overrepresentation of
differentially abundant proteins. The striking exception to this pattern was the group of
proteins belonging to the SaeR regulon (Fig. 1B), which were present in signiﬁcantly
larger amounts in the rho mutant. In the cellular proteome, 14 SaeRS-dependent
proteins exhibited increased amounts under at least one of the four conditions and 27
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were more abundant in the exoproteome. Apart from these, proteome changes in the
rho mutant could not be assigned to distinct regulatory circuits or stress signatures.
Impact of Rho deﬁciency on expression of SaeRS-dependent virulence factor
genes. In the comparative proteome analysis of S. aureus HG001 and the Δrho mutant
ST1258, 34 of the 39 proteins encoded by known SaeR-regulated genes (Table 1) could
be identiﬁed. Half of these (17/34) were found exclusively in the exoproteome samples,
and one, SaeS, was found in the cellular proteome. The remaining 16 proteins were
shared by both proteomic fractions, among them cell surface-associated (FnbA, FnbB,
and Sbi) and secreted (Coa, Eap, Ecb, Efb, Emp, Hla, HlgA, LukG, LukH, and SCIN)
proteins. The presence of the latter group in the cellular fraction is assumed to be
largely due to the retention of secreted proteins at the bacterial cell surface (53).
FIG 1 Heat map of protein abundance differences between the Δrho mutant and the parental strain HG001. By mass spectrometry-based proteome analysis,
1,347 proteins were quantiﬁed from S. aureus cells and 999 proteins were quantiﬁed from the supernatant of HG001 and the Δrho mutant grown in RPMI and
TSB medium. (A) Five hundred forty-one of these proteins could be assigned to 30 different transcription factor regulons when including regulons with at least
two quantiﬁed proteins. Log2 ratios (rho mutant versus HG001) of mean protein intensities from three independent experiments are displayed. Signiﬁcantly
changed proteins are marked with a cross. Regulons were extracted from RegPrecise (51) and AureoWiki (52). (B) SaeR-dependent proteins exhibited signiﬁcantly
higher levels in the rho mutant.
Inhibition of S. aureus Rho Increases Virulence Gene Expression ®
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Altogether, 29 out of 34 SaeRS-dependent proteins exhibited signiﬁcantly larger
amounts in the rho mutant under at least one of the four conditions (Fig. 1B and
Table S1). Of the remaining ﬁve proteins, four exhibited slightly (1.5-fold) higher
protein levels in the mutant and one protein (Nuc) remained unchanged under the
conditions of this study, altogether indicating an activation of the Sae system in S.
aureus cells lacking Rho activity. A particularly strong increase (20-fold) was detected
for Emp, Efb, LukG, and Sbi in the cellular proteome and for Emp, Scc, SplB, and
SAOUHSC_01944 in the exoproteome.
The regulatory components of the Sae system are encoded by the autoregulated
saePQRS operon (16, 54). Whereas the membrane-localized SaeS sensor kinase and the
SaeQ membrane protein were exclusively identiﬁed in the cellular or exoproteome
samples, respectively, the SaeR response regulator and the SaeP lipoprotein were
present in both fractions. The levels of all four proteins were increased in the absence
of Rho (Fig. 1), albeit below the 2-fold cutoff in the case of SaeS.
These increased levels of SaeRS-dependent proteins agreed well with the changes
exerted by Rho deﬁciency on the transcriptional level (47), where most of the SaeR
regulon members were among the genes that showed signiﬁcantly higher expression
levels in the Δrho mutant. At a stringent threshold (fold change of 2), 30 of the 39
SaeR target genes were found upregulated, 11 of them under all four conditions
(exponential and stationary growth phases in the two different media).




SAOUHSC_00182 SAOUHSC_00182 SAOUHSC_00182 Unknown function RegPrecise (51)
SAOUHSC_00192 coa Coa Coagulase RegPrecise (51)
SAOUHSC_00354 selX SelX Staphylococcal enterotoxin-like toxin X RegPrecise (51)
SAOUHSC_00392 ssl7 Ssl7 Staphylococcal superantigen-like protein 7 RegPrecise (51)
SAOUHSC_00394 ssl9 Ssl9 Staphylococcal superantigen-like protein 9 RegPrecise (51)
SAOUHSC_00399 ssl11 Ssl11 Staphylococcal superantigen-like protein 11 RegPrecise (51)
SAOUHSC_00400 SAOUHSC_00400 SAOUHSC_00400 Unknown function RegPrecise (51)
SAOUHSC_00402 lpl3 Lpl3 Lipoprotein-like protein RegPrecise (51)
SAOUHSC_00714 saeS SaeS Sensor histidine kinase RegPrecise (51)
SAOUHSC_00715 saeR SaeR Response regulator RegPrecise (51)
SAOUHSC_00716 saeQ SaeQ Transmembrane protein SaeQ RegPrecise (51)
SAOUHSC_00717 saeP SaeP Lipoprotein SaeP RegPrecise (51)
SAOUHSC_00816 emp Emp Extracellular matrix protein-binding protein 21
SAOUHSC_00818 nuc Nuc Nuclease 24
SAOUHSC_01110 ecb Ecb Fibrinogen-binding protein-like protein RegPrecise (51)
SAOUHSC_01114 efb Efb Extracellular ﬁbrinogen-binding protein RegPrecise (51)
SAOUHSC_01115 scc Scc Fibrinogen-binding protein precursor-like protein RegPrecise (51)
SAOUHSC_01121 hla Hla Alpha-hemolysin RegPrecise (51)
SAOUHSC_01938 splD SplD Serine protease SplD RegPrecise (51)
SAOUHSC_01939 splC SplC Serine protease SplC RegPrecise (51)
SAOUHSC_01941 splB SplB Serine protease SplB RegPrecise (51)
SAOUHSC_01942 splA SplA Serine protease SplA RegPrecise (51)
SAOUHSC_01944 SAOUHSC_01944 SAOUHSC_01944 Unknown function RegPrecise (51)
SAOUHSC_01954 lukD LukD Leukocidin subunit LukD RegPrecise (51)
SAOUHSC_01955 lukE LukE Leukocidin subunit LukE RegPrecise (51)
SAOUHSC_02160 map2 Map2 Truncated Map protein RegPrecise (51)
SAOUHSC_02161 eap/map Eap/Map Extracellular adherence protein RegPrecise (51)
SAOUHSC_02163 hlb-1 Hlb-1 Beta-hemolysin (truncated) 23
SAOUHSC_02167 scn SCIN Staphylococcal complement inhibitor RegPrecise (51)
SAOUHSC_02169 chp CHIPS Chemotaxis inhibitory protein 26
SAOUHSC_02171 sak Sak Staphylokinase RegPrecise (51)
SAOUHSC_02241 lukG LukG Leukocidin subunit LukG RegPrecise (51)
SAOUHSC_02243 lukH LukH Leukocidin subunit LukH RegPrecise (51)
SAOUHSC_02706 sbi Sbi Second immunoglobulin-binding protein RegPrecise (51)
SAOUHSC_02708 hlgA HlgA Gamma-hemolysin subunit HlgA 25
SAOUHSC_02709 hlgC HlgC Gamma-hemolysin subunit HlgC RegPrecise (51)
SAOUHSC_02710 hlgB HlgB Gamma-hemolysin subunit HlgB RegPrecise (51)
SAOUHSC_02802 fnbB FnbB Fibronectin-binding protein B 27
SAOUHSC_02803 fnbA FnbA Fibronectin-binding protein A 27
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Impact of higher levels of SaeRS-dependent virulence factors in a murine
infection model. The Sae system is a major virulence regulatory system of S. aureus
and was shown to be important for this bacterium’s virulence after bloodstream
infection (55). By expressing a constitutively active version of SaeS from S. aureus
Newman (19) in S. aureus USA300 LAC, it was shown previously that constitutive high
expression of the SaeR regulon increases virulence in a murine model of bacteremia
(56). Therefore, we investigated whether a Rho-deﬁcient S. aureus strain producing
higher levels of SaeRS-dependent virulence factors would be more virulent under these
in vivo conditions. Female BALB/c mice were infected with S. aureus HG001, the Δrho
mutant ST1258, or a complementing strain in which rho is expressed from a plasmid
introduced into strain ST1258. A signiﬁcant decrease in the survival rate was observed
when mice were infected with the mutant compared to the parental strain, whereas
virulence of the complemented strain was similar to that of the parental strain (Fig. 2).
These results demonstrate the pathophysiological relevance of higher levels of major
virulence factors caused by inactivation of the transcription termination factor Rho.
Effects of Rho inhibition by bicyclomycin on antisense transcription in S.
aureus. BCM is an antibiotic that speciﬁcally inhibits Rho, and reducing Rho function by
BCM signiﬁcantly elevates antisense transcription in E. coli (48). Most Gram-positive
bacteria are resistant to BCM because Rho is usually not essential in these bacteria.
Known exceptions are Micrococcus luteus (57) and M. tuberculosis (50, 58). The latter,
however, displays resistane to BCM, which can be explained by a low afﬁnity of its Rho
protein for this drug (59). With regard to S. aureus, it was shown previously (40) that an
E. coli strain in which the rho gene is replaced by the S. aureus rho gene is still
responsive to BCM addition, indicating that S. aureus Rho is inhibited by BCM. Since S.
aureus Rho is sensitive to BCM, we sought to assess for the ﬁrst time the impact of BCM
on the transcriptional proﬁle of a Gram-positive pathogen, which also enabled us to
analyze whether all effects observed in the rho mutant were directly caused by the lack
of Rho’s transcription termination activity.
We initially compared the effects of rho deletion and the impact of BCM on
antisense transcription in S. aureus. To this end, HG001 was treated with different
concentrations of BCM during exponential growth in RPMI medium. RPMI medium was
selected for these experiments because global gene expression proﬁles of S. aureus
cells grown in RPMI medium and human plasma were previously shown to be largely
similar (47). BCM was added to the cultures at an optical density at 600 nm (OD600) of
0.2, and growth was pursued for 70 min (60). RNA was extracted from HG001 cells
harvested at an OD600 of 0.2 and grown for 70 min with or without BCM as well as from
FIG 2 Survival analysis of mice infected with the parental strain HG001, a Δrho mutant, or the rho
complemented strains. Six- to 8-week-old female mice were infected intravenously with 8  107 CFU of
HG001 (n  8), the Δrho mutant (n  8), and the complemented strain (n  8). Body weight loss and
disease activity index were monitored until day 5 postinfection. Mice with a weight loss of more than
20% of the starting body weight were sacriﬁced and recorded as dead. The survival rate was signiﬁcantly
different between the parental strain and the Δrho mutant (P  0.0121) and between the Δrho mutant
and the complemented strain (P  0.0088). Differences were tested for statistical signiﬁcance by the
Gehan-Breslow-Wilcoxon test.
Inhibition of S. aureus Rho Increases Virulence Gene Expression ®
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Δrho mutant (ST1258) cells harvested at an OD600 of 0.2 and 70 min later. For Northern
blot analysis, asRNAs were selected which exhibited increased levels in the rho mutant
as revealed by the previous tiling array study (47). Treatment of S. aureus with BCM at
a concentration of 20 g/ml, which reduces Rho function in E. coli without affecting cell
growth (57), did not result in increased asRNA levels. However, as exempliﬁed for S597,
Northern blot analysis revealed an increase in asRNA levels after treatment with
40 g/ml of BCM, albeit still signiﬁcantly lower than the rho mutant (Fig. 3). Upon
inhibition of Rho activity with 80 g/ml of BCM, transcript levels in the parental strain
reached those observed in the rho mutant. Growth of S. aureus was not affected under
these conditions.
To analyze the effects of BCM treatment on antisense transcription at a global level,
we compared the transcriptome of the parental strain grown in RPMI medium with or
without 40 or 80 g/ml of BCM to that of the Δrho mutant using Agilent microarrays.
Bacteria harvested before BCM treatment at an OD600 of 0.2 were included in the
analysis. In the previous tiling array study (47), 26 of 145 asRNAs identiﬁed in S. aureus
HG001 were detected at elevated levels in the rho mutant. Of these, 21 asRNAs are
represented on the Agilent custom microarray used in this study. The analysis revealed
that 14 of these 21 asRNAs exhibited 1.5- to 9-fold-higher levels in the rho mutant
under the growth condition applied here, which all showed similar or slightly higher
levels in the BCM-treated parental strain (80 g/ml) compared to the rho mutant
(Fig. 4A and Table S2).
Expression of SaeRS-dependent virulence factor genes under conditions of
bicyclomycin treatment. We then sought to explore if BCM treatment of S. aureus
would also result in larger amounts of secreted virulence factors, as would be expected
if the effect of Rho on the Sae system is directly linked to its transcription termination
activity. Therefore, we analyzed SaeRS-dependent gene expression and the amounts of
extracellular proteins after treatment of the parental strain compared to the Δrho
mutant. Microarray data revealed higher expression levels of the SaeR regulon genes in
the presence of BCM in the parental strain (Fig. 4B and 5A and Table S2), demonstrating
activation of the Sae system through inhibition of Rho by this antibiotic. Induction of
these genes increased in a dose-dependent manner and reached levels comparable to
FIG 3 Northern blot analysis of antisense transcription in the absence of active Rho. (A) Transcript levels
of asRNA S597 were analyzed by Northern blotting using RNA samples (7 g per lane) of S. aureus HG001
treated with BCM (40 or 80 g/ml) and the Δrho mutant. Upon treatment with BCM and in the mutant,
a speciﬁc band with a size of about 2.3 kb as well as larger transcripts accumulating in the size range of
the 23S rRNA were detected. These S597-speciﬁc bands were already observed in a previous analysis of
Δrho mutant samples (47). Numbers at left are sizes in bases. For the chromosomal location of the S597
gene, see the S. aureus Expression Data Browser at http://genome.jouy.inra.fr/cgi-bin/aeb/viewdetail.py
?idS597_1363050_1363769_1. (B) The methylene blue-stained rRNA bands as control for equal loading
of RNA.
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the rho mutant at the highest BCM concentration (80 g/ml). For individual genes, Rho
inhibition by BCM led to even stronger effects than those observed in the mutant (coa,
efb, fnbA, fnbB, and scc), whereas BCM-mediated induction of other genes (chp, emp,
scn, seIX, ssl7, and SAOUHSC_00182) was slightly lower than in the mutant. For example,
chp, encoding the chemotaxis inhibitory protein CHIPS, was 6- and 8-fold induced by
BCM (40 and 80 g/ml, respectively), but there was a 15-fold expression difference
between the Δrho mutant and the untreated parental strain. Samples taken in early
exponential phase (OD600 of 0.2) served as a control to determine low expression levels
of SaeR-regulated genes before BCM treatment (Fig. 4B).
For exoproteome analysis, culture supernatants of S. aureus HG001 grown with or
without 80 g/ml BCM and of the Δrho mutant ST1258 were collected at an OD600 of
0.2 before BCM treatment and 70 min later. Proteins from the supernatants were
enriched using StrataClean resin beads and analyzed by mass spectrometry. The
analysis resulted in the quantiﬁcation of 776 proteins, of which 41 showed signiﬁcantly
higher abundance in the rho mutant than in the parental strain in exponential growth
phase (70 min after treatment), whereas only six proteins were present in smaller
amounts (Table S3). As depicted in Fig. 5B, higher levels of SaeRS-dependent virulence
factors were observed in the BCM-treated HG001 samples than in untreated controls,
conﬁrming activation of the Sae system in response to inhibition of Rho. With the
exception of SAOUHSC_00400, all proteins present in signiﬁcantly larger amounts in the
rho mutant than in the parental strain were induced by BCM treatment (Fig. 5B).
In addition, we compared the effects caused by Rho deﬁciency and BCM
treatment of S. aureus, respectively, by examining all proteins with a signiﬁcantly
and 2-fold-higher abundance in the rho mutant than in the parental strain (Ta-
ble S3). The majority (35/41) of these proteins exhibited increased levels in response
to BCM treatment, which were, however, in most cases not as high as in the rho
mutant. The remaining proteins were not affected by BCM treatment or exhibited
slightly reduced levels. The levels of three proteins (SdrD, EsxA, and SAOUHSC_
02145) present in signiﬁcantly smaller amounts in the rho mutant were also reduced
FIG 4 Transcriptome analysis of S. aureus treated with bicyclomycin. Box plots of relative expression levels showing 21 asRNAs of S. aureus
identiﬁed by Mäder et al. (47) (A) and 39 genes belonging to the SaeR regulon (B). Samples from the parental strain (HG001) and the
mutant (rho) were collected in early exponential growth phase at an OD600 of 0.2 (early exp) and 70 min later (exp). At an OD600 of 0.2,
HG001 cells were treated with 40 or 80 g/ml BCM, resulting in two additional samples after 70 min (BCM treatment). Expression of
antisense RNAs and SaeRS-dependent virulence factor genes increased in the parental strain after treatment with BCM in a dose-
dependent manner. Log2-transformed relative expression levels are shown for two independent experiments.
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by BCM treatment of the parental strain. Strikingly, one protein of unknown
function (SAOUHSC_00622) showed strongly increased amounts in the rho mutant,
both in the cellular and in the extracellular fractions, but no effect upon inhibition
of Rho function by BCM (Tables S1 and S3), which might point to a speciﬁc cellular
function of the Rho protein in addition to its transcription termination activity.
Proteome analysis of the rho complemented strain revealed that ectopic reintro-
duction of the rho gene reverted the levels of this protein to almost those of the
parental strain (data not shown), conﬁrming that high SAOUHSC_00622 levels in S.
aureus ST1258 were due to Rho deﬁciency.
DISCUSSION
The analyses presented here assessed the physiological importance of Rho-
dependent transcription termination in S. aureus. The rho gene is not essential for
viability of S. aureus (40) and can be inactivated without affecting growth under in vitro
conditions. Nonetheless, a previous study using strand-speciﬁc tiling arrays revealed
profound changes in the S. aureus transcriptome caused by Rho inactivation, most
notably a remarkable overall increase in antisense transcription (47). Transcriptome
alterations did not only result from extended transcription beyond mRNA ends or
FIG 5 Heat map of bicyclomycin effects on genes and secreted proteins belonging to the SaeR regulon.
(A) Expression levels of SaeR-dependent genes were determined by microarray analysis. (B) The corre-
sponding proteins were quantiﬁed by mass spectrometry-based analysis after enrichment of proteins from
culture supernatants of S. aureus HG001 treated with BCM and the Δrho mutant. HG001 samples were
collected in exponential growth phase 70 min after addition of BCM (0, 40, or 80 g/ml). Untreated mutant
samples were collected at the same time point. Log2 ratios (BCM-treated HG001 or rho mutant versus
untreated HG001) of mean expression levels (A) and mean protein intensities (B) from two independent
experiments are shown. Signiﬁcantly changed proteins are marked with a cross.
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transcription from cryptic low-level promoters but also involved changes in gene
expression at the level of transcription initiation, as suggested by the fact that the
concerned genes are not preceded by a Rho-dependent termination site. In the present
study, we investigated whether these changes can be attributed to the level and/or
activity of transcriptional regulators that are inﬂuenced by direct effects of Rho deﬁ-
ciency.
In B. subtilis, Rho-controlled transcription was recently shown to affect the activity of
two global regulators, Spo0A and SigD, leading to altered expression of genes involved
in cell motility, bioﬁlm formation, and sporulation (61). A study on the NusA transcrip-
tion factor of B. subtilis showed that by controlling read-through transcription at
suboptimal intrinsic terminators, NusA also affects global gene expression (62). Deple-
tion of this essential protein caused a substantial increase in antisense transcription and
altered the expression of many genes. This included upregulation of the gene encoding
the arginine metabolism regulator AhrC by read-through of a NusA-dependent termi-
nator leading to AhrC target gene activation. Another recent study reported a Rho-
dependent mechanism in E. coli that is involved in induction of rpoS, encoding the
general stress response sigma factor (63).
In the present study, the impact of the absence of Rho on the S. aureus proteome
was analyzed using cellular and extracellular fractions of S. aureus HG001 and its
isogenic Δrho mutant. The analysis showed signiﬁcant differences in the amounts of
several proteins, notably including major virulence factors whose production is con-
trolled by the SaeRS two-component system, a key regulator of virulence gene expres-
sion in staphylococci. The SaeR response regulator controls the expression of approx-
imately 40 genes, most of which encode secreted proteins such as adhesins, toxins, and
immune evasion proteins (Table 1). In the proteome analysis, 34 of the 39 proteins
encoded by known SaeR-regulated genes could be quantiﬁed, of which 29 proteins
exhibited signiﬁcantly larger amounts in the rho mutant.
The regulatory components of the Sae system are encoded by the saePQRS operon
(27). Besides the membrane-bound sensor kinase SaeS and the soluble DNA-binding
response regulator SaeR, two additional proteins, the lipoprotein SaeP and the mem-
brane protein SaeQ, modulate its activity by activating the phosphatase activity of SaeS
(12). A constitutive promoter is responsible for basal levels of SaeS and SaeR, whereas
the promoter in front of saeP is autoinduced by phosphorylated SaeR (16, 54). The four
Sae proteins were found in increased amounts in the proteome of the rho mutant,
albeit below the 2-fold cutoff in the case of SaeS. However, increased amounts of the
regulatory proteins are not assumed to cause an increase in the expression of SaeR
target genes (12, 19), but activation at the saeP promoter is rather the consequence of
higher levels of SaeR phosphorylation in the rho mutant. Thus, our data suggest that in
S. aureus cells lacking Rho activity, the Sae system is activated, which leads to the
observed induction of the SaeR regulon.
The Sae system is known to be induced by different stimuli, in particular host-related
signals. Accessory membrane proteins are thought to be involved in sensing external
signals, and the N-terminal domain of SaeS, composed of two transmembrane helices
with a short extracytoplasmic linker, is responsible for transducing the signals to the
kinase domain (13). Since the kinase activity of SaeS appears to respond to the overall
conformation of the transmembrane domain, any exogenous or endogenous mole-
cules altering the conformation of this domain can affect phosphorylation of SaeR (64).
Accordingly, most of the experimentally investigated intramembrane-sensing histidine
kinases are implicated in responding to cell envelope stress (13). For the Sae system, it
was previously shown that it is stimulated by constitutive activation of the WalR
response regulator involved in cell wall metabolism and autolysis (17). In S. aureus the
activity of autolysins is associated with bioﬁlm formation and the release of genomic
DNA (65, 66). A recent study showed that the amount of extracellular DNA was
decreased in an S. aureus strain lacking both lipase genes (lip/gehA and geh/gehB),
suggesting that these secreted lipases might affect the integrity of the cytoplasmic
membrane (67). Strikingly, in the present study the Geh (or SAL2) protein exhibited
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higher levels in the rho mutant during growth in both media (see Table S1 in the
supplemental material). Thus, the signal that triggers activation of the Sae system under
conditions of Rho deﬁciency may be generated by altered lipase activity affecting
membrane structure.
The serine-aspartate repeat protein SdrD, a cell wall-anchored adhesin, exhibited
strongly decreased levels in the rho mutant under all growth conditions analyzed.
Strikingly, Kuroda et al. (22) found that sdrD and sdrE were downregulated upon
cefoxitin-mediated activation of the Sae system (see below) in S. aureus N315, presum-
ably in an indirect manner. This strongly suggests that the effect of Rho inactivation on
sdrD expression observed in our study is linked to the activation of the Sae system and
thus reinforces the view that SaeS is activated by deletion of rho.
The antibiotic BCM speciﬁcally binds to Rho and inhibits its action by preventing
ATP turnover and RNA translocation (41, 42). Reducing Rho function by BCM had
revealed main physiological roles of Rho in E. coli, including silencing of horizontally
acquired genes (68), preventing the formation of DNA double-strand breaks (38), and
suppression of pervasive antisense transcription (48). In the Gram-positive bacteria B.
subtilis and S. aureus, genome-wide analyses of Rho function were performed using rho
deletion mutants (47, 49, 61). As mentioned above, these studies demonstrated that a
general role of Rho is to suppress or limit bacterial antisense transcription. We now
show that inhibition of Rho activity by BCM similarly leads to increased levels of
antisense transcripts in Rho-proﬁcient S. aureus cells. More importantly, upon inhibition
of Rho activity by BCM, S. aureus produces larger amounts of SaeRS-dependent
virulence factors, reaching levels comparable with those observed in the rho deletion
mutant (Fig. 5). This result indicates that activation of the Sae system under Rho-
deﬁcient conditions is directly linked to Rho’s transcription termination activity and
establishes a new link between antibiotic action and deleterious virulence gene ex-
pression in S. aureus.
Higher levels of SaeRS-dependent virulence factors in the S. aureus mutant lacking
Rho activity can be expected to have an impact under in vivo conditions. To test this
hypothesis, we used a murine bacteremia model and infected mice with S. aureus
HG001, the rho deletion mutant, and a rho complemented strain. Indeed, Rho inacti-
vation signiﬁcantly increased virulence of S. aureus for mice (Fig. 2). In the present
study, we showed that not only inactivation of the rho gene but also inhibition of Rho
activity by BCM causes increased production of SaeRS-dependent virulence factors,
suggesting an impact of the antibiotic BCM on staphylococcal virulence in vivo. Efﬁcient
inhibition of Rho activity inside the host is beyond question, since it constitutes the
basis for BCM treatment of human and animal infections with Gram-negative bacteria
(41), in which Rho is essential for viability.
Previous studies have reported effects of antibiotics on the expression of S. aureus
virulence factors (reviewed in reference 69). Most in vitro data indicate decreased levels
of virulence gene expression upon treatment with ribosome-targeted antibiotics (lin-
ezolid and clindamycin), which was conﬁrmed by in vivo studies (70–74). On the other
hand, cell wall-active antibiotics (-lactams) were shown to increase toxin production
(72, 74, 75). Induction of Panton-Valentine leukocidin expression by -lactam antibiotics
interfering with penicillin-binding protein 1 (PBP1) is mediated by the virulence regu-
lators SarA and Rot (76). Inconsistent results were reported with regard to the effects
of -lactam antibiotics on activation of the Sae system. Cefoxitin, a PBP4-selective
-lactam, was shown to activate the Sae system (22), whereas the nonselective oxacillin
had no effect on the Sae system (14). Importantly, all these studies investigated the
effects of antistaphylococcal agents. In contrast, in the case of BCM an antibiotic
effective against Gram-negative bacteria is implicated in the expression of S. aureus
virulence factors. This may have clinical implications, not only for patients suffering
from mixed infections with different bacterial species but also for patients with a
Gram-negative bacterial infection who are carriers of S. aureus.
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Bacterial strains and growth conditions. The following S. aureus strains were used: HG001 (77), the
isogenic Δrho mutant ST1258 (47), and the complemented strain ST1258 pMKX::rho. Plasmid pMKX is a
derivative of the shuttle vector pMK4 (78), allowing inducible gene expression in S. aureus from the
xylose-inducible promoter of the Staphylococcus xylosus xylA gene, and was constructed in several steps.
A 1.7-kb HindIII-BamHI DNA fragment carrying the S. xylosus xylR xylose repressor gene and the xylA
promoter (79) was ﬁrst puriﬁed from plasmid pRB473-XylR and cloned between the corresponding
restriction sites of plasmid pUC18 to give plasmid pUCXyl. The insert was sequenced, and plasmid
pUCXyl was then used as a matrix to reamplify the 1.7-kb xylR-pxylA fragment by PCR to introduce
appropriate restriction sites. This fragment was cloned into plasmid pMK4 to give the expression vector
pMKX, which was used for gene complementation experiments. Expression of rho from the xylA
promoter was tested in RPMI and brain heart infusion (BHI) media, where it was identical with and
without xylose. mRNA levels of strain ST1258 pMKX::rho were comparable to expression from the native
promoter in the HG001 wild-type strain (see Fig. S2 in the supplemental material).
Bacteria were cultivated in RPMI (with L-glutamine and without phenol red and HEPES; Gibco Life
Technologies, Carlsbad, CA, USA) and tryptic soy broth (TSB; BD, Franklin Lakes, NJ, USA). The cultures
were inoculated with an exponentially growing overnight culture to an optical density at 600 nm (OD600)
of 0.05 and grown with shaking at 37°C. Cells and supernatant were collected in exponential growth
phase (TSB, OD600 of 0.5; RPMI, OD600 of 0.4) and 4 h after entry into stationary phase (Fig. S1).
Sample preparation for mass spectrometric analysis. For investigation of cytoplasmic proteins,
cells were harvested by centrifugation (5 min, 4°C, 10,000 g), washed once with phosphate-buffered
saline (PBS), and frozen in liquid nitrogen. Bacterial cells were resuspended in 25 mM ammonium
bicarbonate buffer and disrupted using FastPrep FP120 (5 times for 30 s each, speed 6.5; Thermo Fisher
Scientiﬁc, Waltham, MA, USA). The culture supernatants were supplemented with bovine serum albumin
(BSA) (5 g/ml), and extracellular proteins were precipitated with trichloroacetic acid (TCA) (80). Protein
concentration was determined by using the Bradford assay (Bio-Rad Laboratories, Munich, Germany).
Proteins of supernatants of BCM-treated S. aureus cells were enriched with StrataClean resin beads
according to the method of Bonn et al. (80) with minor modiﬁcations, namely, using 50 mM Tris buffer
(pH 7) instead of TE buffer (50 mM Tris, 10 mM EDTA, pH 7) and determination of peptide concentrations
by the Pierce quantitative colorimetric peptide assay (Thermo Fisher Scientiﬁc).
Tryptic digest and peptide puriﬁcation were performed as previously described (81) using a C18
ZipTip column (Millipore, Billerica, MA, USA) with a loading capacity of 5 g. Before subjecting the
samples to mass spectrometry, HRM spike-in mix (Biognosys AG, Schlieren, Switzerland) was added.
Mass spectrometric measurements and data analysis. Tryptic peptides were separated by
reversed-phase liquid chromatography (Dionex Ultimate 3000 system; Thermo Fisher Scientiﬁc) coupled
online to electrospray ionization mass spectrometry using a Q Exactive mass spectrometer (Thermo
Fisher Scientiﬁc). The instrumental setup and the data independent acquisition (DIA) method were used
according to the method of Michalik et al. (82) with slight modiﬁcations (Table S4).
The ion library for DIA data analysis was constructed based on a Comet database search using an S.
aureus protein fasta ﬁle from AureoWiki (http://aureowiki.med.uni-greifswald.de/Main_Page) comprising
2,852 protein entries in a target-decoy approach using trypsin/P digest rule with number of tolerable
termini (NTT) 2, 30 ppm (MS1), and 0.01-Da fragment mass tolerance as well as static (sample
preparation-dependent carbamidomethylation; 57.021464) and variable (methionine oxidation; 15.9949)
modiﬁcations. For library construction, previously published (82) and newly generated (Table S5) data
sets were acquired on a Q Exactive mass spectrometer (Thermo Fisher Scientiﬁc).
The results were processed using the Trans-Proteomic Pipeline (TPP; version 4.8.0 philae) (83)
including PeptideProphet and iProphet (84, 85) (minimal peptide length, 7 amino acids). A global protein
false-discovery rate (FDR) of 1% was set using MAYU (86). The ﬁltered peptide spectrum matches were
used to generate the ion library in Spectronaut (v11.0.15038.14.27660 [Asimov]; Biognosys AG, Schlieren,
Switzerland) with the following settings: m/z mass range of 300 to 2,000, 6 to 10 fragments per peptide,
removal of fragments smaller than 3 amino acids, no segmented regression, and a minimum root mean
square error of 0.5. The constructed library consists of 2,154 proteins with 38,570 tryptic peptides.
The analysis of the DIA data (82) was carried out using Spectronaut (v11.0.15038.14.27660 [Asimov];
Biognosys AG, Schlieren, Switzerland) with the settings speciﬁed in Table S4. The reported tandem mass
spectrometry (MS2) areas of ions were analyzed in R (version 3.4.3). The ion intensities were median-
median normalized and subsequently analyzed protein-wise with at least 2 assays/ions per protein using
a Wilcoxon rank sum test against a fold change of 2 against the control sample with multiple test
correction using the Benjamini and Hochberg algorithm. Proteins with an adjusted P value below 0.05
were assumed to be signiﬁcantly regulated. All plots were generated in R using the packages listed in
Table S4.
In vivo infection experiments. (i) Ethics statement. All of the animal studies were approved by the
local government of Franconia, Germany (approval number 55.2-2532-2-155), and performed in strict
accordance with the guidelines for animal care and experimentation of the German Animal Protection
Law and directive 2010/63/EU of the European Union (EU).
(ii) Infection inoculum. Overnight cultures of S. aureus strains HG001, ST1258, and ST1258 pMKX::rho
in BHI medium were diluted to a ﬁnal OD600 of 0.05 in 50 ml fresh BHI medium and grown for 3.5 h at
37°C. After centrifugation, cell pellets were resuspended in BHI with 20% glycerol, aliquoted, and stored
at 80°C. For the generation of in vivo infection inocula, aliquots were thawed and washed twice with
PBS. The desired bacterial concentration (8 107 CFU/100 l) was then adjusted based on the respective
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OD600 values. A sample of the infection inoculum was plated on TSB agar plates in order to control the
infection dose.
(iii) Intravenous S. aureus infection model. Female BALB/c mice (8 per group, 6 weeks old; Janvier
Labs, Le Genest-Saint-Isle, France) were intravenously infected with 8  107 CFU of bacteria via the tail
vein. The mice were housed in individually ventilated cages under normal diet in groups of ﬁve
throughout the experiment with ad libitum access to food and water. During infection, mice were scored
twice a day, and the severity of infection (score; see Table S6) was determined accordingly. If a mouse
reached the humane endpoint with a score of 20 points, this mouse was sacriﬁced and removed from
the experiment. In this case, the mouse was regarded as dead beginning with this time point in the
survival curve (Fig. 2). Signiﬁcant difference in the survival of the three groups of mice was determined
with the Gehan-Breslow-Wilcoxon test (software: GraphPad Prism 5.0).
Transcriptome analysis. RNA was prepared by acid-phenol extraction after mechanical cell disrup-
tion as described previously (49). The quality of the RNA was assessed by means of an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer’s instructions.
For Northern blot analysis, 7 g of total RNA per sample was separated under denaturing conditions
in a 1% agarose gel and transferred onto a positively charged nylon membrane (Roche Pharma AG,
Grenzach-Wyhlen, Germany) by vacuum blotting. After cross-linking (120 mJ/cm2; Stratalinker UV Cross-
linker 1800; Stratagene, CA, USA), hybridization was performed as described previously (87). A biotin-
labeled RNA probe was generated by in vitro synthesis using a T7 RNA polymerase and Bio-16-UTP (Life
Technologies, Carlsbad, CA, USA). PCR synthesis of the templates was performed using the following
oligonucleotides: TTAATTTATTAATTTATTTC (SA_01432_AS_for) and CTAATACGACTCACTATAGGGAGAC
GTATCTCTTTGCTCATCGT (SA_01432_AS_T7rev). Detection of the biotin-labeled probe on the membrane
with IRDye 800CW streptavidin (Li-Cor Biosciences, Lincoln, NE, USA) was performed with the Odyssey
CLx imager according to the instructions of the manufacturer (Li-Cor Biosciences, Lincoln, NE, USA).
For microarray analysis, 5 g of total RNA (two biological replicates per condition) was subjected to
cDNA synthesis. Synthesis and ﬂuorescence labeling of cDNA followed a strand-speciﬁc method using
the FairPlay III microarray labeling kit (Agilent Technologies, Santa Clara, CA, USA) and actinomycin D
(Calbiochem, Merck KGaA, Darmstadt, Germany) (88). The samples were labeled with Cy5, and a
reference pool containing equal amounts of RNA from each sample was labeled with Cy3. Seventy-ﬁve
nanograms of the two cDNAs were hybridized together to the microarray according to Agilent’s
hybridization, washing, and scanning protocol (two-color microarray-based gene expression analysis,
version 5.5). Data were extracted and processed using Feature Extraction software (version 11.5.1.1). For
each gene, the median of the individual probe ratios was calculated. For data analysis, Genedata Analyst
software (Genedata AG, Switzerland) was used.
Data availability. The microarray data set is available from NCBI’s Gene Expression Omnibus (GEO)
database (accession number GSE112980). Mass spectrometry data were deposited in the MassIVE
database (https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp?redirectauth) and can be accessed
via accession number MSV000082270.
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